Tag: monoclonal
Exclusive: Antibody against multiple emerging SARS-CoV-2 variants
A broadly neutralizing highly potent human monoclonal antibody developed in India against multiple emerging SARS-CoV-2 variants
COVID-19: India bets big on monoclonal antibodies amid mega industry &...
CSIR through its NMITLI program approves a multi institutional project to develop human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in patients. The project will be implemented by National Centre for Cell Science (NCCS), IIT-Indore and PredOmix Technologies with Bharat Biotech International, as the commercialization partner...........................
Synthetic alternative to monoclonal antibodies enter humans for the first time
US based Inovio Pharmaceuticals' DNA-encoded monoclonal antibody (dMAb™) platform has made a leap forward with first-in-human trial that will target Zika infection...............
Biocon registers strong performance, profits up by 17%
Biocon in the first quarter of the financial year 2016-17, has reported the revenues of Rs 952 crore; net profit up by 17 percent at Rs 147 crore ....